Patent Issued for Virus (USPTO 12016949).

A patent has been issued to iosBio Ltd. for a method of delivering a transgene to target cells in a patient through oral administration of viral particles. The patent describes the use of adenoviral vectors, which have been extensively studied and are capable of effectively transducing both dividing and non-dividing cells. The inventor has shown that adenoviral particles carrying insulin were able to reduce glucose levels in diabetic rats when orally administered. The patent also includes claims for a tablet or capsule for oral administration, as well as methods of preparing and delivering the viral particles. [Extracted from the article]